Get alerted on the PharmaSources E-Newsletter and Pharma Sources Insight E-Compilation!
Note: You can unsubscribe from the alerts at any time.
Advertising

CanSino gets COVID-19 vaccine patent from China’s IP regulator

expresspharmaAugust 18, 2020

Tag: CanSino , COVID-19 vaccine , Ad5-nCoV

PharmaSources Customer Service